PNC Managed Account Solutions’s Idexx Laboratories IDXX Stock Holding History

PNC Managed Account Solutions’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$54K	Buy	+85	New	+$46.9K	0.01%	363

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

PNC Managed Account Solutions's IDXX Position: Q2 2021 in Review

PNC Managed Account Solutions opened a new position in Idexx Laboratories (IDXX) in Q2 2021: 85 shares worth $54K. The stake represents 0.01% of the portfolio and ranks #363 among its holdings.

1,032 funds tracked by Wall St. Rank hold IDXX as of Q2 2021.

PNC Managed Account Solutions held 85 shares of Idexx Laboratories worth $54K as of Q2 2021.
Idexx Laboratories was a new PNC Managed Account Solutions position in Q2 2021.
Idexx Laboratories made up 0.01% of PNC Managed Account Solutions's portfolio in Q2 2021, its #363 holding.
1,032 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2021.

Based on PNC Managed Account Solutions's 13F filing for Q2 2021, filed 6 Aug 2021.